Tg er laaaangt ifra død
“We found that the great majority of pts with PDAC have multiple KRAS mutations and
that some mutations change during the course of the study. Single mutation vaccines
and small molecules targeting single mutations are therefore not likely to be effective
while therapies targeting a mix of KRAS mutations such as TG01/GM-CSF should be more
beneficial.”